Detalhe da pesquisa
1.
The Expression of Anti-Müllerian Hormone Type II Receptor (AMHRII) in Non-Gynecological Solid Tumors Offers Potential for Broad Therapeutic Intervention in Cancer.
Biology (Basel)
; 10(4)2021 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33917111
2.
[Physiopathological mechanisms of immune-related adverse events induced by anti-CTLA-4, anti-PD-1 and anti-PD-L1 antibodies in cancer treatment]. / Mécanismes physiopathologiques des effets secondaires des immunothérapies par anticorps anti-CTLA-4, anti-PD-1 et anti-PD-L1 dans le traitement du cancer.
Bull Cancer
; 105(11): 1033-1041, 2018 Nov.
Artigo
em Francês
| MEDLINE | ID: mdl-30244981